N@N

Mead Johnson to Present at Barclays Capital Back-to-School Consumer Conference

^{Published on 2010-08-31 10:35:43 - Market Wire}
 

GLENVIEW, Ill.--([ BUSINESS WIRE ])--Mead Johnson Nutrition Company (NYSE: MJN) announced today that it will present at the Barclays Capital 2010 Back-to-School Consumer Conference in Boston on Tuesday, Sept. 7, 2010. The presentation by Peter G. Leemputte, Senior Vice President and CFO, will begin at approximately 1:30 p.m. ET and will be webcast live on the Internet. During his remarks, Mr. Leemputte will reaffirm the companya™s previously issued annual non-GAAP earnings guidance of $2.35 to $2.40 per share. Including specified items estimated at $0.26 per share, GAAP earnings guidance is $2.09 to $2.14 per share.

To access the webcast go to [ meadjohnson.com ] and click on the Investor tab, Overview. A replay will be available approximately one hour after the conclusion of the live webcast at meadjohnson.com under the Investor tab, Events and Presentations.

Forward-Looking Statements

Certain statements in this news release are forward looking as defined in the Private Securities Litigation Reform Act of 1995. These statements, which are identified by words such as aexpects,a aintendsa and abelieves,a involve certain risks and uncertainties that may cause actual results to differ materially from expectations as of the date of this news release. These risks include, but are not limited to: (1) the ability to sustain brand strength, particularly the Enfa family of brands; (2) the effect on the companya™s reputation of real or perceived quality issues; (3) the adverse effect of commodity price increases; (4) increased competition from branded, private label, store and economy-branded products; (5) the effect of an economic downturn on consumersa™ purchasing behavior and customersa™ ability to pay for product; (6) inventory reductions by customers; (7) the adverse effect of changes in foreign currency exchange rates; (8) legislative, regulatory or judicial action that may adversely affect the companya™s ability to advertise its products or maintain product margins; (9) the possibility of changes in the Women, Infant and Children (WIC) program, or increases in levels of participation in WIC; and (10) the ability to develop and market new, innovative products. For additional information on these and other factors, see the risk factors identified in the companya™s periodic reports, including the annual report on Form 10-K for 2009, quarterly reports on Form 10-Q and current reports on Form 8-K, filed with, or furnished to, the Securities and Exchange Commission, available upon request or at [ meadjohnson.com ]. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

About Mead Johnson

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in 60 markets worldwide. The companya™s mission is to nourish the world's children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The companya™s aEnfaa family of brands, including Enfamil® infant formula, is the worlda™s leading brand franchise in pediatric nutrition. For more information, visit meadjohnson.com.